Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3230777 | 1.00 | THRB (0.50) | THRBALDH1A1TSHRLMNA | |
| SCHEMBL30236594 | 1.00 | THRB (0.50) | THRBALDH1A1TSHRLMNA | |
| SCHEMBL789340 | 1.00 | — | — | |
| SCHEMBL29426245 | 1.00 | THRB (0.50) | THRBALDH1A1TSHRLMNA | |
| SCHEMBL30600321 | 0.94 | THRB (0.46) | THRBALDH1A1TSHR | |
| SCHEMBL504018 | 0.94 | THRB (0.55) | THRBALDH1A1TSHRLMNA | |
| SCHEMBL8968 | 0.94 | — | — | |
| SCHEMBL27028519 | 0.94 | THRB (0.55) | THRBALDH1A1TSHRLMNA | |
| SCHEMBL402114 | 0.88 | THRB (0.50) | THRBALDH1A1TSHRLMNA | |
| SCHEMBL129302 | 0.88 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 347 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120192264-A | Preparation method of itramod | 深圳市华先医药科技有限公司 | 2025-06-24 | — | — | CN | claimed |
| WO-2025055886-A1 | COMPOUND, LIGHT EMITTING LAYER RAW MATERIAL, ORGANIC LIGHT EMITTING DEVICE, ELECTRONIC DEVICE, AND PREPARATION METHOD | 华为技术有限公司 | 2025-03-20 | — | — | WO | claimed |
| CN-115667219-B | Preparation method of (S) -2-amino-3- (4- (2, 3-dimethylpyridine-4-yl) phenyl) methyl propionate diacid salt | 杭州中美华东制药有限公司 | 2024-11-15 | — | — | CN | claimed |
| CN-118619980-A | Synthesis method of adapalene intermediate 3- (1-adamantane) -4-methoxyphenylboronic acid | 北京万全德众医药生物技术有限公司 | 2024-09-10 | — | — | CN | claimed |
| CN-117567254-A | Indane ring biphenyl liquid crystal compound and preparation method and application thereof | 武汉轻工大学 | 2024-02-20 | — | — | CN | claimed |
| CN-117510315-A | dl- (±) -beta-methyl amyl terphenyl liquid crystal compound, preparation method and application thereof | 武汉轻工大学 | 2024-02-06 | — | — | CN | claimed |
| CN-116715576-A | Method for synthesizing alpha-bromoaryl acetic acid compound | 四川农业大学 | 2023-09-08 | — | — | CN | claimed |
| CN-111868049-B | Process for preparing somatostatin modulators | 克林提克斯医药股份有限公司 | 2023-06-30 | — | — | CN | claimed |
| CN-113135949-B | Tetraphenylethylene borate derivative hypochlorite fluorescent probe | 济南大学 | 2022-11-25 | — | — | CN | claimed |
| CN-113173940-B | Synthesis and application of anti-melanoma prodrug activated by cascade of double bioactive factors | 湖南大学 | 2022-08-09 | — | — | CN | claimed |
| CN-114854032-A | Preparation and application of water-soluble lanthanide AIE fluorescent nanoparticles | 西北师范大学 | 2022-08-05 | — | — | CN | claimed |
| CN-114349752-A | Electronic transmission layer modification material capable of being processed by solution and preparation method and application thereof | 华能新能源股份有限公司 | 2022-04-15 | — | — | CN | claimed |
| CN-114072143-A | Synthesis of CRAC channel inhibitors | 钙医学公司 | 2022-02-18 | — | — | CN | claimed |
| CN-117024411-B | Isoquinoline as HPK1 inhibitor | 豪夫迈·罗氏有限公司 | 2026-05-19 | — | — | CN | disclosed |
| CN-122036717-A | Near-infrared AIE fluorescent probe and preparation method and application thereof | 徐州医科大学 | 2026-05-15 | — | — | CN | disclosed |
| CN-116715689-B | Synthesis method of flurbiprofen and intermediate thereof | 珠海市海瑞德生物科技有限公司 | 2025-12-12 | — | — | CN | disclosed |
| WO-2010045503-A1 | BORON-CONTAINING SMALL MOLECULES AS ANTI-PROTOZOAL AGENTS | ANACOR PHARMACEUTICALS, INC. (US) | 2010-04-22 | — | — | WO | disclosed |
| US-20090291917-A1 | Boron-Containing Small Molecules as Anti-Inflammatory Agents | ANACOR PHARMACEUTICALS, INC. (US) | 2009-11-26 | — | — | US | disclosed |
| WO-2009111676-A2 | BORON-CONTAINING SMALL MOLECULES AS ANTI-INFLAMMATORY AGENTS | ANACOR PHARMACEUTICALS, INC (US) | 2009-09-11 | — | — | WO | disclosed |
| WO-2005009104-A2 | BENZOIC AND PHENYL ACETIC ACID DERIVATIVES AS HNF-4 MODULATORS | LIGAND PHARMACUETICALS INCORPORATED (US) | 2005-02-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090291917-A1 | Boron-Containing Small Molecules as Anti-Inflammatory Agents | NFKBIA, LITAF, CD68 | THRB 770/4885ALDH1A1 3761/4885TSHR 4168/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.